The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
β Scribed by Lisa A. Kottschade; Jeff A. Sloan; Miroslaw A. Mazurczak; David B. Johnson; Bronagh P. Murphy; Kendrith M. Rowland; DeAnne A. Smith; Alan R. Berg; Philip J. Stella; Charles L. Loprinzi
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 259 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Lamotrigine, an antiepileptic agent, has been reported as being effective in reducing symptoms of neuropathy associated with various etiologies. Based on such data, a multicenter doubleβblind, placeboβcontrolled, randomized trial was conducted to evaluate the effect of l
## Abstract ## BACKGROUND. The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data, a multicenter, doubleβblind, placeboβcontrolled, crossover, randomized trial was conducted to evaluate the effec
Background. A single-institution, prospective, randomized open trial was performed to compare ondansetron and granisetron in the prevention of chemotherapyrelated nausea and vomiting. The effect of antemetic drugs was analyzed indipendently for patients treated with highly emetogenic chemotherapy (S